We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Alliance to Build Human Protein Interaction Map

By Biotechdaily staff writers
Posted on 02 Aug 2002
A collaboration to generate maps showing the interaction of different proteins has been formed by Genetix Group plc (New Milton, UK; www.genetix.com) and the Human Genome Mapping Project Resource Center of the Medical Research Council (MRC HGMPRC, Cambridge, UK; www.hgmp.mrc.ac.uk). More...
Genetix provides automated systems and services for genomic and proteomic research.

The two groups will work together to develop instrumentation and systems required to map these interactions to gain a better understanding of how proteins function. The project will initially use yeast as a medium, later switching to mammalian cells so the protein interactions can be validated in humans. The resulting knowledge will be used by scientists and researchers throughout the world to advance the understanding of how proteins interact to perform complex biologic processes, to identify the causes of disease, and to develop novel drugs against specific protein targets.

To measure interactions between the protein products of the estimated 30,000-50,000 genes would generate about one billion data points. The participants say their skills in systems integration, software development, and microbiology will enable them to develop the new technologies needed to complete this research in a timely and accurate manner.

"An overwhelming amount of information has been produced by mapping the human genome, but it will only be useful with a manual or map to help us understand how the component parts work to complete the whole,” said Dr. Duncan Campbell, director of the
MRC HGMPRC.




Related Links:
Genetix
MRC

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Chromogenic Culture System
InTray™ COLOREX™ ECC
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.